These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2412058)

  • 21. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.
    Cocks TM; Angus JA
    Nature; 1983 Oct 13-19; 305(5935):627-30. PubMed ID: 6621711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin and arterial vessels.
    Vanhoutte PM; Cohen RA; Van Nueten JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S421-8. PubMed ID: 6206351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular 5-HT1-like receptors mediating vasoconstriction and vasodilatation: their characterization and distribution in the intact canine cardiovascular system.
    Cambridge D; Whiting MV; Butterfield LJ; Marston C
    Br J Pharmacol; 1995 Mar; 114(5):961-8. PubMed ID: 7780651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for the putative 5-HT7 receptor mediating direct relaxation to 5-hydroxytryptamine in canine cerebral blood vessels.
    Terrón JA
    Ann N Y Acad Sci; 1998 Dec; 861():283. PubMed ID: 9928292
    [No Abstract]   [Full Text] [Related]  

  • 26. Ketanserin prevents platelet aggregation and endotoxin-induced pulmonary vasoconstriction.
    Meuleman TR; Hill DC; Port JD; Stanley TH; Pace NL; Mohammad SF
    Crit Care Med; 1983 Aug; 11(8):606-11. PubMed ID: 6872549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin.
    Meschig R; Breuer J; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin enhances sympathetic vasoconstrictor responses in rat isolated perfused tail artery by activation of postjunctional serotonin-2 receptors.
    Medgett IC; Fearn HJ; Rand MJ
    Clin Exp Pharmacol Physiol; 1984; 11(4):343-6. PubMed ID: 6518663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries.
    Morecroft I; MacLean MR
    Br J Pharmacol; 1998 Sep; 125(1):69-78. PubMed ID: 9776346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin.
    Breuer J; Meschig R; Breuer HW; Arnold G
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S64-6. PubMed ID: 2412062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery.
    Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR
    Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin.
    Vanhoutte P; Amery A; Birkenhäger W; Breckenridge A; Bühler F; Distler A; Dormandy J; Doyle A; Frohlich E; Hansson L
    Hypertension; 1988 Feb; 11(2):111-33. PubMed ID: 3277910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ketanserin on 5-hydroxytryptamine-induced cerebrovascular spasm in the cat.
    Vällfors B; Dahlström A; Boström S; Ahlman H
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S60-3. PubMed ID: 2412061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of serotonin in the regulation of the circulatory system].
    Buczko W
    Pol Tyg Lek; 1985 Apr; 40(16):469-72. PubMed ID: 3160011
    [No Abstract]   [Full Text] [Related]  

  • 38. Vascular effects of serotonin and ischemia.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S15-9. PubMed ID: 1369711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.
    Van Nueten JM; Janssens WJ; Xhonneux R; Janssen PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S10-5. PubMed ID: 2459506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ketanserin on hypoxia-induced vasoconstriction in isolated lungs.
    Helgesen KG; Bjertnaes L
    Int J Microcirc Clin Exp; 1986; 5(1):65-72. PubMed ID: 2941385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.